Patents by Inventor Shioko Kimura

Shioko Kimura has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Therapeutic use of SCGB3A2
    Patent number: 8828936
    Abstract: The present disclosure is generally related to methods of using the secretory protein SCGB3A2 for promoting lung development and treating lung disease. Some embodiments are, for example, methods for treating and inhibiting the development of neonatal respiratory distress. Other embodiments are methods of promoting lung development in damaged or diseased lungs. Also disclosed are methods for inhibiting lung damage due to anti-cancer agents.
    Type: Grant
    Filed: August 5, 2013
    Date of Patent: September 9, 2014
    Assignee: The United States of America, as Represented by the Secretary, Department of Health and Human Services
    Inventors: Shioko Kimura, Reiko Kurotani
  • THERAPEUTIC USE OF SCGB3A2
    Publication number: 20130316947
    Abstract: The present disclosure is generally related to methods of using the secretory protein SCGB3A2 for promoting lung development and treating lung disease. Some embodiments are, for example, methods for treating and inhibiting the development of neonatal respiratory distress. Other embodiments are methods of promoting lung development in damaged or diseased lungs. Also disclosed are methods for inhibiting lung damage due to anti-cancer agents.
    Type: Application
    Filed: August 5, 2013
    Publication date: November 28, 2013
    Applicant: The United States of America, as Represented by the Secretary, Department of Health and Human Serv
    Inventors: Shioko Kimura, Reiko Kurotani
  • SCGB3A2 as a growth factor and anti-apoptotic agent
    Patent number: 8501688
    Abstract: The present disclosure is generally related to methods of using the secretory protein SCGB3A2 for promoting lung development and treating lung disease. Some embodiments are, for example, methods for treating and inhibiting the development of neonatal respiratory distress. Other embodiments are methods of promoting lung development in damaged or diseased lungs. Also disclosed are methods for inhibiting lung damage due to anti-cancer agents.
    Type: Grant
    Filed: February 6, 2012
    Date of Patent: August 6, 2013
    Assignee: The United States of America, as Represented by the Secretary, Department of Health and Human Services
    Inventors: Shioko Kimura, Reiko Kurotani
  • SCGB3A2 AS A GROWTH FACTOR AND ANTI-APOPTOTIC AGENT
    Publication number: 20120202740
    Abstract: The present disclosure is generally related to methods of using the secretory protein SCGB3A2 for promoting lung development and treating lung disease. Some embodiments are, for example, methods for treating and inhibiting the development of neonatal respiratory distress. Other embodiments are methods of promoting lung development in damaged or diseased lungs. Also disclosed are methods for inhibiting lung damage due to anti-cancer agents.
    Type: Application
    Filed: February 6, 2012
    Publication date: August 9, 2012
    Inventors: Shioko Kimura, Reiko Kurotani
  • SCGB3A2 as a growth factor and anti-apoptotic agent
    Patent number: 8133859
    Abstract: The present disclosure is generally related to methods of using the secretory protein SCGB3A2 for promoting lung development and treating lung disease. Some embodiments are, for example, methods for treating and inhibiting the development of neonatal respiratory distress. Other embodiments are methods of promoting lung development in damaged or diseased lungs. Also disclosed are methods for inhibiting lung damage due to anti-cancer agents.
    Type: Grant
    Filed: September 27, 2007
    Date of Patent: March 13, 2012
    Assignee: The United States of America as represented by the Department of Health and Human Services
    Inventors: Shioko Kimura, Reiko Kurotani
  • SCGB3A2 AS A GROWTH FACTOR AND ANTI-APOPTOTIC AGENT
    Publication number: 20100093621
    Abstract: The present disclosure is generally related to methods of using the secretory protein SCGB3A2 for promoting lung development and treating lung disease. Some embodiments are, for example, methods for treating and inhibiting the development of neonatal respiratory distress. Other embodiments are methods of promoting lung development in damaged or diseased lungs. Also disclosed are methods for inhibiting lung damage due to anti-cancer agents.
    Type: Application
    Filed: September 27, 2007
    Publication date: April 15, 2010
    Inventors: Shioko Kimura, Reiko Kurotani
  • Human ugrp (uteroglobin-related protein) 1 promoter and its use
    Publication number: 20040234982
    Abstract: The nucleic acid sequence of mammalian Uteroglobin Related Protein (e.g., UGRP1 genes are disclosed. Specifically the mouse and the human UGRP1 promoters are disclosed herein. Vectors are disclosed that include these promoters, and these promoters operably linked to a heterologous nucleic acid sequence. Host cells are disclosed that are transformed with theses UGRP1 promoter sequences. A method is disclosed for determining the diagnosis or prognosis of a respiratory disorder in a subject, utilizing the UGRP1 promoter sequence. In one embodiment, the disorder is asthma. In another embodiment, the subject is a human, and the presence of a polymorphism in the UGRP1 promoter sequence is used to diagnose, or determine the prognosis of a respiratory disorder. One specific, non-limiting example of a polymorphism disclosed herein is a polymorphism at position −112 of the UGRP1 promoter.
    Type: Application
    Filed: December 10, 2003
    Publication date: November 25, 2004
    Inventors: Shioko Kimura, Tomoaki Niimi